Interestingly, IL-12-expressing murine CD19-targeting CAR T cells have shown promising results in established lymphomas in part because the IL-12-induced epitope-spreading of the tumor-associated antigens without a requirement for lymphodepletive preconditioning [94]. Here, CD19 is linked to neoplasm.